Highlights: 83% successful trades & account up 6%!
July was another successful month for The Oxen Group. We saw our Oxen Picks account grow by over 6% due to numerous successful trades (15 out of 18, or 83!). In July, the market recoiled back from a stream of losses as tech and financials led the month. Playing the oil and energy ETFs was particularly profitable, as the energy market continues to be volatile. We are looking for the month of Augus for a defining month as we enter a post-recessionary market that will either continue to look forward or hit some bumps in the road. With the market being extremely overbought and overvalued, we may spend the beginning of the month somewhat sideways as investors await more big news and more bargains to present themselves.
Here are more more statistics from the month of July, trading my account:
Our account increased from 4481.77 to 4758.47 in month of July. That is an increase of 6.17%.
We had 15 positive trading days out of 18.
Six of 18 days gave us 3% gains or more.
We began a 3% stop loss policy. This was beneficial on two days when the stock we bought trailed below 3% from our entry price.
Our account has now moved up 58.62% in 86 days of trading or 4 months.
I came across this chart today, categorize it in the "for what its worth" department:
[Click on charts for larger view]
Let’s see how the above seasonality charts compare with my own SPX chart:
SPX – 120 minute
Counting eight bars from the right we can see the gap-up open to a new summer high in Thursday’s first bar. But look underneath at the Elliott Oscillator. Eight bars from the right is a major divergence, not even close to a new high for the move. If the S&P breaks below 985 Monday and stays below it, we get a trend sell signal that should carry at least 50 points lower. That would coincide with a break down of the trend regression channels with even more bearish implications.
Zooming out, here is the Weekly chart with Fibonacci levels and the False Bar Stochastic:
This is where the above seasonality chart is especially poignant. Prices have engaged the first major Fibonacci level of 38.2%. A turn down here, accompanied by a break down of the regression channels and another crossing of the FBS down below it’s signal line adds up to compelling evidence of a change of trend that could lead to the initiation of the next impulsive leg down.
If this analysis sounds familiar, it is because it has been hanging around these charts for the past six weeks. The consensus of the bulls is that we are in a new bull market, that the recession is over, or about to be over, that the government has pumped enough liquidity into the system to have saved the day and that the bear market is finished and its loyal adherents, especially those like me who say the worst is yet to come, just don’t have a clue.
Remember, in March, this bearish take was the view of the many. Today, August 1, it is the view of the few, as another piece of the puzzle falls into place.
All of this is predicatedupon a break below support on the above two-hour S&P chart.This has not yet occurred and unless and until it does, the trend is higher. [Ilene's emphasis]
That’s it for a Saturday in August. It’s 110 here in the desert and about time for a cold one.
Here’s an interesting article by Susan Blackmore. While there are parts of Susan’s article I might disagree with, the general idea opens up a whole new set of memes, for me – the third replicators. So, the first replicators are our genes. The second replicators are memes – ideas, the basis of cultural evolution. Using the machinery of the second replicators (human minds), we have have built the third replicators.
WE HUMANS have let loose something extraordinary on our planet – a third replicator – the consequences of which are unpredictable and possibly dangerous.
What do I mean by "third replicator"? …
About 4 billion years after the appearance of the first replicator, something extraordinary happened. Members of one species of lumbering robot began to imitate one another. Imitation is a kind of copying, and so a new evolutionary process was born. Instead of cellular chemistry copying the order of bases on DNA, a sociable species of bipedal ape began to use its big brain to copy gestures, sounds and other behaviours. This copying might not have been very accurate, but it was enough to start a new evolutionary process. Dawkins called the new replicators "memes". A living creature, once just a vehicle of the first replicator, was now the copying machinery for the next…
Memes are a new kind of information – behaviours rather than DNA – copied by a new kind of machinery – brains rather than chemicals inside cells. This is a new evolutionary process because all of the three critical stages – copying, varying and selection – are done by those brains. So does the same apply to new technology?
There is a new kind of information: electronically processed binary information rather than memes. There is also a new kind of copying machinery: computers and servers rather than brains. But are all three critical stages carried out by that machinery?
Machines now copy information to other machines without human intervention…
“Treasury Secretary Timothy Geithner and National Economic Council Director Larry Summers both sidestepped questions on Obama’s intentions about taxes. Geithner said the White House was not ready to rule out a tax hike to lower the federal deficit; Summers said Obama’s proposed health care overhaul needs funding from somewhere.“
The Wall Street owned insurer Customer Asset Protection Company, known as Capco, may not be an off-shore company. But it sure operates like one of those Cayman Island based tax shelters president Barack Obama has targeted.
Capco is the mysterious company owned by WallStreet giants like Morgan Stanley and Goldman Sachs, banks like JPMorgan Chase and Wells Fargo, smaller brokerage firms, and Fidelity, the mutual fund giant. Years ago Capco moved from New York to Vermont, where state law enables it to operate without disclosing much about its finances.
It’s official address is 100 Bank Street, Suite 610, in Burlington, Vermont. But if you go there, you won’t find an office marked with the name Capco. Instead, you’ll find an office marked Marsh Captive Solutions, which is a division of Marsh & McClennen that administers captive insurance companies. A total of 185 business are run out of Suite 610.
This brings to mind the story Obama used to tell on the campaign trail about “the outrage of a building in the Cayman Islands that had over 12,000 business — businesses claim this building as their headquarters. And I’ve said before, either this is the largest building in the world or the largest tax scam in the world.”
So how big is Suite 610? We suspect it’s a small office with a bunch of secretary types and filing cabinets. The reason it houses so many companies is that these captive insurance companies are registered in Vermont to avoid tighter regulations in other states.
For those of you who missed it, today Capco was dragged out of the shadows by New York Times reporter Zach Kouwe. The company was formed to insure customer accounts above the $550,000 of SIPIC insurance. The idea was that customers didn’t need to worry about the insolvency of their broker because Capco was insuring it. But now Capco appears to be massively insolvent, facing a possible $11 billion in claims from the collapse of Lehman Brothers with only about $150 million with which to meet them. New York State regulators are worried, and the Wall Street owners could wind up having to pay the bill.
First, we have Corus, which reported a negative Tier 1 Ratio. That is, they are formally "in the hole" in terms of assets vs. liabilities. This is never supposed to happen – but it did, "Prompt Corrective Action" be damned.
Based on these adjustments, the Bank’s core capital ratio stood at negative 5.78% as of March 31, 2009. The Bank’s total risk based capital ratio as of March 31, 2009 stood at negative 5.52%. Both of these ratios result in the Bank being considered critically under-capitalized under regulatory prompt corrective action standards.
Yet Prompt Corrective Action (PCA) – a law, by the way, not a suggestion – has once again not been followed.
Finally, we have Colonial. I made a nice chunk of coin shorting and PUTting that turkey last year, when their CEO (and a lot of other people) said they were "very conservative." Uh huh. My read of their balance sheet said they were (like many other regional banks) massively over-exposed to condo construction loans in….. you guessed it…. Florida (which incidentally is what killed Corus.) Oops. But here’s the money quote on Colonial:
If the FDIC were to seize Colonial, it would be the sixth-largest seizure, by assets, in American history. Such a large failure could strain the bank safety net. Colonial has $20 billion in deposits, while the FDIC insurance fund has dropped below $15 billion. The FDIC wouldn’t have to cover every dime, but when Florida’s BankUnited, with $12.8 billion in assets, failed earlier this year, it cost regulators nearly $5 billion.
Add all three of these up and tell me what you think is going on?
These three are not small banks. They are significant regional institutions, unlike the tiny little banks that we hear about every Friday after the close of business.
Here’s the nut to the story above: When BankUnited was
With two reports a day, and often more, readers sometimes complain that keeping tabs on the thoughts of the various Gavekal analysts can be a challenge. So as the year draws to a close, it may be helpful if we recap the main questions confronting investors and the themes we strongly believe in, region by region.
1. A Chinese Marshall Plan?
When we have conversations with clients about China – which typically we do between two and four times a day – the talk invariably ...
Analysts at Oppenheimer initiated coverage of Twitter Inc (NYSE: TWTR) Friday by issuing a Perform rating and setting a $36.00 price target. Twitter is a global social networking platform with over 280 million active users.
While Oppenheimer analysts fully recognize the strength in Twitter as a company, they believe that Twitter’s stock is appropriately priced at current levels. “While TWTR is the best Internet platform for real-time content discovery, we believe that the stock’s current valuation of 10x 2015E sales, a 52% premium to peers, fully reflects future prospects based on current growth rates.”
Between November and December 2014, Twitter insiders have sold more than $...
Those who took advantage of markets at Fib levels were rewarded. However, this looked more a 'dead cat' style bounce than a genuine bottom forming low. This can of course change, and one thing I will want to see is narrow action near today's high. Volume was a little light, but with Christmas fast approaching I would expect this trend to continue.
The S&P inched above 2,009, but I would like to see any subsequent weakness hold the 38.2% Fib level at 1,989.
The Nasdaq offered itself more as a support bounce, with a picture perfect play off its 38.2% Fib level. Unlike the S&P, volume did climb in confirmed accumulation. The next upside c...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
Stocks have needed a reason to take a breather and pull back in this long-standing ultra-bullish climate, with strong economic data and seasonality providing impressive tailwinds -- and plummeting oil prices certainly have given it to them. But this minor pullback was fully expected and indeed desirable for market health. The future remains bright for the U.S. economy and corporate profits despite the collapse in oil, and now the overbought technical condition has been relieved. While most sectors are gathering fundamental support and our sector rotation model remains bullish, the Energy sector looks fundamentally weak and continues to ran...
Stocks got off to a rocky start on the first trading day in December, with the S&P 500 Index slipping just below 2050 on Monday. Based on one large bullish SPX options trade executed on Wednesday, however, such price action is not likely to break the trend of strong gains observed in the benchmark index since mid-October. It looks like one options market participant purchased 25,000 of the 31Dec’14 2105/2115 call spreads at a net premium of $2.70 each. The trade cost $6.75mm to put on, and represents the maximum potential loss on the position should the 2105 calls expire worthless at the end of December. The call spread could reap profits of as much as $7.30 per spread, or $18.25mm, in the event that the SPX ends the year above 2115. The index would need to rally 2.0% over the current level...
I officially bought 250 shares of EZCH at $18.76 and sold 300 shares of IGT at $17.09 in Market Shadows' Virtual Portfolio yesterday (Fri. 11-21).
Click here for Thursday's post where I was thinking about buying EZCH. After further reading, I decided to add it to the virtual portfolio and to sell IGT and several other stocks, which we'll be saying goodbye to next week.
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well PSW Subscribers....I am still here, barely. From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.
First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices. Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment. Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer. For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at firstname.lastname@example.org with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW)
nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Site owned and operated by PSW Investments, LLC. Contact us at: 403 Central Avenue, Hawthorne, NJ 07506. Phone: (201) 743-8009. Email: email@example.com.